Back to Search
RONALD CIRILLO, M.D.
M.D.
Specialist
NPI: 1831186659Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
026298(CT)
Research & Publications (20)
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
PMID 19232440·J Neuroimmunol·2009
7-preclinical
Giardia and Cryptosporidium in inflowing water and harvested shellfish in a lagoon in Southern Italy.
PMID 18760378·Parasitol Int·2009
7-preclinical
An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo.
PMID 18662971·J Leukoc Biol·2008
7-preclinical
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
PMID 18270703·Cancer Chemother Pharmacol·2008
7-preclinical
[Exercise stress test and dobutamine stress echocardiography for the prognostic stratification after uncomplicated acute myocardial infarction].
PMID 17650690·G Ital Cardiol (Rome)·2007
8-other
Arrest of preterm labor in rat and mouse by an oral and selective nonprostanoid antagonist of the prostaglandin F2alpha receptor (FP).
PMID 17618756·Am J Obstet Gynecol·2007
3-trial
Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.
PMID 17570160·BMC Pregnancy Childbirth·2007
7-preclinical
Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment.
PMID 17526805·J Pharmacol Exp Ther·2007
7-preclinical
Tumor necrosis factor (TNF)-soluble high-affinity receptor complex as a TNF antagonist.
PMID 17495128·J Pharmacol Exp Ther·2007
7-preclinical
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
PMID 16302826·J Med Chem·2005
7-preclinical
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.
PMID 16127437·Nat Med·2005
7-preclinical
Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.
PMID 15999997·J Med Chem·2005
7-preclinical
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system.
PMID 15494530·J Immunol·2004
7-preclinical
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.
PMID 15210584·Br J Pharmacol·2004
7-preclinical
[Risk stratification after acute myocardial infarction: limitations of dobutamine stress echocardiography in females].
PMID 15116866·Ital Heart J Suppl·2004
8-other
Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
PMID 15080898·Mol Cell Neurosci·2004
7-preclinical
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.
PMID 12767275·J Steroid Biochem Mol Biol·2003
7-preclinical
[Infusion of flecainide in a patient with atrial fibrillation and latent Brugada's syndrome has determined modifications of the electrocardiogram similar to those of a septal myocardial infarct].
PMID 12762263·Ital Heart J Suppl·2003
5-case
Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
PMID 12660315·J Pharmacol Exp Ther·2003
7-preclinical
GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families.
PMID 11879720·Diabetes Res Clin Pract·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 80 MILL RIVER ST, SUIE 1100
STAMFORD, CT 06902 - Phone
- (203) 348-5818
Quick Facts
- NPI
- 1831186659
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile